ARTICLE | Company News
Santarus, S2 Therapeutics Inc., VeroScience sales and marketing update
November 22, 2010 8:00 AM UTC
Santarus launched Cycloset bromocriptine in the U.S. to treat Type II diabetes. VeroScience and S2 granted Santarus exclusive rights in the U.S. to commercialize the timed-release tablet in September...